The success of the Phase 3 study reverberated beyond the clinic, sending the company’s shares up more than a third in a ...

Kelonia is developing a next-gen blood cancer treatment that’ll reprogram T-cells to help patients’ immune systems fight ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

The stock market held near highs this week as Intel and chipmakers offset ServiceNow and software woes. Apple CEO Tim Cook is ...

Eli Lilly said Monday it will spend up to $7 billion to buy privately held Kelonia Therapeutics for its suite of cancer treatments.